Azithromycin to prevent complications of rheumatic heart disease
Treatments studied
Part of Bones, joints & muscles, Heart & circulation, Infections, Skin clinical trials.
This study tests whether an antibiotic called azithromycin can help prevent complications and disease progression in young people with rheumatic heart disease (RHD—a type of heart valve damage). You would take this medication monthly and visit the clinic for check-ups to see if it helps protect your heart.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 10 and 18 years old
- You have been diagnosed with mild or moderate rheumatic heart disease
- You can attend monthly clinic visits
- You are not allergic to penicillin or other antibiotics
- You have not already started another preventive antibiotic for your heart condition
- You are willing and able to take study medication and follow the study schedule reliably
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a low-dose antibiotic (azithromycin) can prevent lung infections in young children with structural lung damage. It aims to see if taking it regularly can keep their lungs healthier and reduce the need for antibiotics.
This study is testing whether a vaccine can prevent rheumatic heart disease in children. It involves children aged 5 to 8 years who are healthy, live in certain areas, and have no history of heart problems. The study will check children's hearts with an ultrasound and follow them over time.
This trial tests whether azithromycin (an antibiotic) can improve outcomes for babies and young children in the ICU who have RSV causing serious breathing problems. It mainly looks at children who start strong breathing support soon after RSV symptoms begin.
This trial tests whether the antibiotic azithromycin can help children in the hospital who are having asthma-like breathing symptoms. If you qualify, your child may get azithromycin as part of the study and will be monitored closely for side effects and breathing improvement.
This trial tests whether it is safe to stop taking daily penicillin for children and teens whose rheumatic heart disease has improved or stayed mild. If you took part in the GOALIE study and your heart condition is now stable, this study may help determine if you can safely stop medication.
This Phase 4 study tests whether a long course of azithromycin can reduce flare-ups in people with chronic obstructive pulmonary disease (COPD) who have had recent exacerbations. It also looks at mucus properties and how flare-ups happen.
Hear when a new Rheumatic Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.